These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11348014

  • 1. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.
    Ganea D, Delgado M.
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):101-10. PubMed ID: 11348014
    [Abstract] [Full Text] [Related]

  • 2. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M, Sun W, Leceta J, Ganea D.
    J Immunol; 1999 Oct 15; 163(8):4213-23. PubMed ID: 10510358
    [Abstract] [Full Text] [Related]

  • 3. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun 15; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M, Leceta J, Gomariz RP, Ganea D.
    J Immunol; 1999 Oct 01; 163(7):3629-35. PubMed ID: 10490956
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity.
    Ganea D, Delgado M.
    Crit Rev Oral Biol Med; 2002 Apr 15; 13(3):229-37. PubMed ID: 12090463
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 15; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Immunol; 1999 Feb 15; 162(4):2358-67. PubMed ID: 9973516
    [Abstract] [Full Text] [Related]

  • 10. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression.
    Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D.
    Ann N Y Acad Sci; 2000 Feb 15; 921():68-78. PubMed ID: 11193881
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    Ganea D, Rodriguez R, Delgado M.
    Cell Mol Biol (Noisy-le-grand); 2003 Mar 15; 49(2):127-42. PubMed ID: 12887096
    [Abstract] [Full Text] [Related]

  • 12. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.
    Delgado M, Gonzalez-Rey E, Ganea D.
    FASEB J; 2004 Sep 15; 18(12):1453-5. PubMed ID: 15231725
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP.
    J Immunol; 1999 Jan 15; 162(2):1200-5. PubMed ID: 9916753
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.
    Delgado M.
    Biochem Biophys Res Commun; 2002 May 03; 293(2):771-6. PubMed ID: 12054537
    [Abstract] [Full Text] [Related]

  • 16. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M.
    Ann N Y Acad Sci; 2000 May 03; 921():92-102. PubMed ID: 11193883
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
    Martínez C, Juarranz Y, Abad C, Arranz A, Miguel BG, Rosignoli F, Leceta J, Gomariz RP.
    J Leukoc Biol; 2005 May 03; 77(5):729-38. PubMed ID: 15661828
    [Abstract] [Full Text] [Related]

  • 18. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
    J Cell Physiol; 2009 Oct 03; 221(1):75-83. PubMed ID: 19496170
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.
    Delgado M, Ganea D.
    J Neuroimmunol; 2000 Oct 02; 110(1-2):97-105. PubMed ID: 11024538
    [Abstract] [Full Text] [Related]

  • 20. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide.
    Delgado M, Leceta J, Abad C, Martinez C, Ganea D, Gomariz RP.
    J Neuroimmunol; 1999 Sep 01; 99(1):61-71. PubMed ID: 10496178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.